Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13574 | 763 | 38.6 | 80% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2932 | 2237 | CONVECTION ENHANCED DELIVERY//GLIADEL//CARMUSTINE WAFERS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CONVECTION ENHANCED DELIVERY | Author keyword | 210 | 72% | 22% | 166 |
| 2 | GLIADEL | Author keyword | 27 | 76% | 2% | 19 |
| 3 | CARMUSTINE WAFERS | Author keyword | 19 | 80% | 2% | 12 |
| 4 | BCNU WAFER | Author keyword | 15 | 82% | 1% | 9 |
| 5 | INTERSTITIAL CHEMOTHERAPY | Author keyword | 15 | 62% | 2% | 16 |
| 6 | INTRATUMORAL DRUG DELIVERY | Author keyword | 12 | 75% | 1% | 9 |
| 7 | CONVECTION ENHANCED DRUG DELIVERY | Author keyword | 11 | 78% | 1% | 7 |
| 8 | BCNU WAFERS | Author keyword | 10 | 73% | 1% | 8 |
| 9 | FUNCT NEUROSURG GRP | Address | 7 | 56% | 1% | 9 |
| 10 | INTERSTITIAL INFUSION | Author keyword | 6 | 80% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CONVECTION ENHANCED DELIVERY | 210 | 72% | 22% | 166 | Search CONVECTION+ENHANCED+DELIVERY | Search CONVECTION+ENHANCED+DELIVERY |
| 2 | GLIADEL | 27 | 76% | 2% | 19 | Search GLIADEL | Search GLIADEL |
| 3 | CARMUSTINE WAFERS | 19 | 80% | 2% | 12 | Search CARMUSTINE+WAFERS | Search CARMUSTINE+WAFERS |
| 4 | BCNU WAFER | 15 | 82% | 1% | 9 | Search BCNU+WAFER | Search BCNU+WAFER |
| 5 | INTERSTITIAL CHEMOTHERAPY | 15 | 62% | 2% | 16 | Search INTERSTITIAL+CHEMOTHERAPY | Search INTERSTITIAL+CHEMOTHERAPY |
| 6 | INTRATUMORAL DRUG DELIVERY | 12 | 75% | 1% | 9 | Search INTRATUMORAL+DRUG+DELIVERY | Search INTRATUMORAL+DRUG+DELIVERY |
| 7 | CONVECTION ENHANCED DRUG DELIVERY | 11 | 78% | 1% | 7 | Search CONVECTION+ENHANCED+DRUG+DELIVERY | Search CONVECTION+ENHANCED+DRUG+DELIVERY |
| 8 | BCNU WAFERS | 10 | 73% | 1% | 8 | Search BCNU+WAFERS | Search BCNU+WAFERS |
| 9 | INTERSTITIAL INFUSION | 6 | 80% | 1% | 4 | Search INTERSTITIAL+INFUSION | Search INTERSTITIAL+INFUSION |
| 10 | BCNU | 6 | 16% | 5% | 35 | Search BCNU | Search BCNU |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTERSTITIAL CHEMOTHERAPY | 69 | 56% | 11% | 83 |
| 2 | CONVECTION ENHANCED DELIVERY | 48 | 29% | 18% | 141 |
| 3 | CARMUSTINE WAFERS | 29 | 88% | 2% | 14 |
| 4 | INTRACEREBRAL CLYSIS | 27 | 83% | 2% | 15 |
| 5 | GLIADEL WAFERS | 23 | 76% | 2% | 16 |
| 6 | BCNU WAFERS | 19 | 80% | 2% | 12 |
| 7 | POSITIVE PRESSURE INFUSION | 17 | 79% | 1% | 11 |
| 8 | LOCAL CHEMOTHERAPY | 15 | 44% | 3% | 26 |
| 9 | RECURRENT GLIOMAS | 13 | 28% | 5% | 39 |
| 10 | CONTROLLED RELEASE POLYMERS | 12 | 44% | 3% | 20 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Convection-enhanced delivery to the central nervous system | 2015 | 2 | 110 | 75% |
| The role of Gliadel wafers in the treatment of high-grade gliomas | 2013 | 13 | 34 | 79% |
| Future of convection-enhanced delivery in the treatment of brain tumors | 2010 | 40 | 34 | 74% |
| A comprehensive outlook on intracerebral therapy of malignant gliomas | 2011 | 29 | 54 | 57% |
| Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers | 2012 | 69 | 99 | 24% |
| Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations | 2014 | 8 | 86 | 48% |
| Convection-enhanced delivery of nanocarriers for the treatment of brain tumors | 2009 | 92 | 122 | 44% |
| The sequential use of carmustine wafers (Gliadel (R)) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review | 2011 | 20 | 24 | 63% |
| Current status of local therapy in malignant gliomas - A clinical review of three selected approaches | 2013 | 28 | 186 | 24% |
| Drug delivery strategies for the treatment of malignant gliomas | 2012 | 25 | 122 | 41% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FUNCT NEUROSURG GRP | 7 | 56% | 1.2% | 9 |
| 2 | CANC TARGETED DRUG DELIVERY | 6 | 100% | 0.5% | 4 |
| 3 | INTRAMURAL OURCES | 6 | 100% | 0.5% | 4 |
| 4 | AMBI S | 4 | 56% | 0.7% | 5 |
| 5 | CHILDRENS MEM MED FEINBERG MED | 2 | 67% | 0.3% | 2 |
| 6 | FUNCT NEUROSURG GRP CLIN SCI | 2 | 67% | 0.3% | 2 |
| 7 | HATCH MRI | 2 | 67% | 0.3% | 2 |
| 8 | HUNTERIAN BRAIN TUMOR | 2 | 67% | 0.3% | 2 |
| 9 | LMMN | 2 | 50% | 0.4% | 3 |
| 10 | ESCUELA INGN CIVIL GEOMAT | 2 | 27% | 0.8% | 6 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000238034 | EXTRACELLULAR SPACE//EXTRASYNAPTIC TRANSMISSION//NONSYNAPTIC DIFFUSION NEUROTRANSMISSION |
| 2 | 0.0000149992 | POLYANHYDRIDES//POLYANHYDRIDE//POLYANHYDRIDE ESTER |
| 3 | 0.0000148696 | INTRACAROTID CHEMOTHERAPY//RMP 7//INTRACAROTID INFUSION |
| 4 | 0.0000134818 | TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA |
| 5 | 0.0000125487 | BRAIN TARGETING//SMART DRUG DELIVERY//ANGIOPEP 2 |
| 6 | 0.0000119659 | LIPID NANOCAPSULES//U1066//U646 |
| 7 | 0.0000110726 | DIFFUSE INTRINSIC PONTINE GLIOMA//BRAINSTEM GLIOMA//PONTINE GLIOMA |
| 8 | 0.0000096599 | INTERSTITIAL FLUID PRESSURE//EDWIN L STEELE//CANCER DETECTION AND TREATMENT |
| 9 | 0.0000093117 | COVERED ROD//OSMOTIC RELEASE//FREEZE THAW POLYMERIZATION |
| 10 | 0.0000082993 | EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS |